SciRhom

Martinsried, Germany

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

$68.1M raised

Jul 2024

Series A

Top Investors

HTGF (High-Tech Gruenderfonds)Kurma PartnersWellington PartnersHospital for Special SurgeryAndera Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SciRhom raised?

SciRhom has raised $68.1M in total funding. The most recent round was Series A. The last funding was announced in July 2024.

Who are SciRhom's investors?

SciRhom's investors include HTGF (High-Tech Gruenderfonds), Kurma Partners, Wellington Partners, Hospital for Special Surgery, Andera Partners.

Where is SciRhom headquartered?

SciRhom is headquartered in Martinsried, Germany.

What does SciRhom do?

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

What stage is SciRhom at?

SciRhom is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 9, 2024.

MLA

"SciRhom — Funding & Investors." VCBacked, July 9, 2024, https://www.vcbacked.co/company/scirhom. Accessed June 17, 2026.

APA

VCBacked. (2024). SciRhom — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/scirhom

Wikipedia (cite web)

{{cite web |title=SciRhom — Funding & Investors |url=https://www.vcbacked.co/company/scirhom |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 9, 2024.